MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.
about
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesisMiRNAs and miRNA Polymorphisms Modify Drug ResponseRegulation of molecular pathways in ischemia-reperfusion injury after liver transplantation.Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placentaResistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.The multidrug resistance 1 gene Abcb1 in brain and placenta: comparative analysis in human and guinea pigMicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein.MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapyRole of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease.Friend or foe: the role of microRNA in chemotherapy resistance.The network of P-glycoprotein and microRNAs interactions.MicroRNAs and their relevance to ABC transporters.Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.MDR1 will play a key role in pharmacokinetic changes under hypoxia at high altitude and its potential regulatory networks.Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients.The long chain α-tocopherol metabolite α-13'-COOH and γ-tocotrienol induce P-glycoprotein expression and activity by activation of the pregnane X receptor in the intestinal cell line LS 180.MicroRNAs and Cancer Drug Resistance.Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells.Length variants of the ABCB1 3'-UTR and loss of miRNA binding sites: possible consequences in regulation and pharmacotherapy resistance.Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.Epigenetic regulation of drug transporter expression in human tissues.The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia.Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression.Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma.Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3.microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview.ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.MicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp ExpressionRegulations of P-Glycoprotein/ABCB1/MDR1 in Human Cancer Cells
P2860
Q26783563-297C113E-31F3-42E9-90FA-38F478FEE64AQ28079075-61A34293-1CFB-4C7C-A770-728FC0D72992Q30407113-D9B2BCF8-2D39-432A-A142-201DB29341B2Q31133417-E6A78C00-F1C3-45E8-81DE-778419F1F9F9Q33850064-B1700286-BD3E-45B4-8CD4-21B85EBEC073Q34420934-BBE5BD70-069B-476A-8BCE-4BE738FDAED5Q34571491-823524DB-63F3-4881-BB81-89424BCC9041Q34786557-5F795709-4861-4B62-8DD2-40217A42A280Q36618667-7E0220F8-26A7-4DD5-B42F-35F96419E97EQ38097092-3DEC2F8A-8FEF-4C6F-99C2-A964C4BF9ED6Q38102553-DC97BF8B-FB43-4E86-8491-1172272DF88BQ38152293-29EC2E84-9D1E-4932-B206-CE038108BD8CQ38197247-0AAC6C14-7E46-41AB-AEA9-C309B48EFC60Q38243832-D46A615D-236D-4AF6-8118-4EF73DD9BD7AQ38339659-95E708C5-00CE-47CC-982D-3B3D384E58E9Q38435024-88F15EA4-DAB5-4503-8B95-135B06DC45B3Q38742088-14B444CD-D253-4B27-8D6D-3434914B9175Q38748118-3FDC0102-FCA4-4B22-ABE9-3ACD8CE686FAQ38749023-211A6DB1-7430-4F5D-8650-0AD0DA38E612Q38792633-3FB971CB-326E-4818-B213-EA66E8C576DAQ38906160-4F6CE6F2-D708-42ED-9A14-4ED40B26FFE2Q38908841-D5F04EF2-A3BD-4633-A4A9-F6D64A0B4124Q38942246-27C92E97-4863-4FEF-AE03-45189647DF75Q41037347-9F51D536-DE6E-4773-A494-B3E0C6EBDF60Q41441070-631333B7-51E0-4998-8198-7F82CD55D29DQ45641138-939E9CE5-C64B-4F61-89A1-C8F9D057AF6CQ46253187-7FD67A7E-F309-4021-A2A0-67D9CD95ADD9Q47375547-698254A6-823D-4742-8651-7FAC4916F97BQ55000594-85CFD6BF-E1B7-4C0B-A0E8-9ACB49053493Q55403266-D119E7A8-8491-4345-A11A-EE753AF0947CQ58698331-A0EA7ADF-4D30-48C0-B802-287D52AD362DQ59072649-2DE6CAF4-E307-498A-A197-0B75E643599D
P2860
MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MicroRNA-145 post-transcriptio ...... n intestinal epithelial cells.
@en
MicroRNA-145 post-transcriptio ...... n intestinal epithelial cells.
@nl
type
label
MicroRNA-145 post-transcriptio ...... n intestinal epithelial cells.
@en
MicroRNA-145 post-transcriptio ...... n intestinal epithelial cells.
@nl
prefLabel
MicroRNA-145 post-transcriptio ...... n intestinal epithelial cells.
@en
MicroRNA-145 post-transcriptio ...... n intestinal epithelial cells.
@nl
P2093
P356
P1476
MicroRNA-145 post-transcriptio ...... in intestinal epithelial cells
@en
P2093
Hideki Mizutani
Masahiro Okuda
Misato Yamamoto
Saori Miyazaki
Takuya Iwamoto
P304
P356
10.1124/MOL.112.081844
P577
2012-11-19T00:00:00Z